EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 3.0

Profile of Luspatercept in the Treatment of Anemia in Adults with Non-Transfusion-Dependent β-Thalassemia (NTDT): Design, Development and Potential Place in Therapy

Khaled M Musallam iD, Ali T Taher iD, Antonis Kattamis iD, Kevin H M Kuo iD, Sujit Sheth iD, Maria Domenica Cappellini iD

Drug Design, Development and Therapy · 2023

DOI: 10.2147/dddt.s368584 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Drug Design, Development and Therapy, 2023. Verfasst von Khaled M Musallam und 5 weiteren Autor:innen. Beteiligte Einrichtung: Thalassemia Center, Burjeel Medical City, Abu Dhabi, United Arab Emirates. Hauptthemen laut MEDLINE: beta-Thalassemia. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

beta-ThalassemiaHumansAdultImmunoglobulin Fc FragmentsActivin Receptors, Type IIHemoglobinsRecombinant Fusion Proteins

Stichwörter der Autor:innen

anemiaineffective erythropoiesisironmanagementthalassemiatransfusion

Substanzen

Immunoglobulin Fc FragmentsActivin Receptors, Type IIHemoglobinsluspaterceptRecombinant Fusion Proteins

Autor:innen und Institutionen

  • Thalassemia Center, Burjeel Medical City, Abu Dhabi, United Arab Emirates.
  • Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon.
  • First Department of Pediatrics, National and Kapodistrian University of Athens, Athens, Greece.
  • Division of Hematology, University of Toronto, Toronto, ON, Canada.
  • Division of Hematology and Oncology, Department of Pediatrics, Weill Cornell Medicine, New York, NY, USA.
  • Department of Clinical Sciences and Community, University of Milan, Ca' Granda Foundation IRCCS Maggiore Policlinico Hospital, Milan, Italy.

ORCID-Profile: Khaled M Musallam, Ali T Taher, Antonis Kattamis, Kevin H M Kuo, Sujit Sheth, Maria Domenica Cappellini

Zitieren

APA

Musallam, K. M., Taher, A. T., Kattamis, A., Kuo, K. H. M., Sheth, S., & Cappellini, M. D. (2023). Profile of Luspatercept in the Treatment of Anemia in Adults with Non-Transfusion-Dependent β-Thalassemia (NTDT): Design, Development and Potential Place in Therapy. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s368584

Vancouver

Musallam KM, Taher AT, Kattamis A, Kuo KHM, Sheth S, Cappellini MD. Profile of Luspatercept in the Treatment of Anemia in Adults with Non-Transfusion-Dependent β-Thalassemia (NTDT): Design, Development and Potential Place in Therapy. Drug Design, Development and Therapy. 2023. doi:10.2147/dddt.s368584

BibTeX
@article{Musallam2023,
  author = {Musallam, Khaled M and Taher, Ali T and Kattamis, Antonis and Kuo, Kevin H M and Sheth, Sujit and Cappellini, Maria Domenica},
  title = {Profile of Luspatercept in the Treatment of Anemia in Adults with Non-Transfusion-Dependent β-Thalassemia (NTDT): Design, Development and Potential Place in Therapy},
  journal = {Drug Design, Development and Therapy},
  year = {2023},
  doi = {10.2147/dddt.s368584}
}
Kostenlos starten →